Gujarat diabetes drug market jumps 30% on semaglutide surge | Ahmedabad News
Ahmedabad: Gujarat posted its highest-ever single-month spike in diabetes drug sales in April 2026, with the market expanding 30% year-on-year to Rs 118 crore, driven by the entry of affordable semaglutide-based alternatives after patent expiry in India and several global markets. Doctors say these drugs, initially prescribed mainly for diabetes care, are now increasingly being…